XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2

Revenue (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021 USD ($) segment	Jun. 30, 2020 USD ($) segment	Jun. 30, 2021 USD ($) segment	Jun. 30, 2020 USD ($) segment
Revenue
Number of reportable segments | segment	4	4	4	4
Net sales	$ 10,223	$ 7,328	$ 20,679	$ 15,054
U.S.
Revenue
Net sales	3,581	2,638	7,419	5,494
Int'l
Revenue
Net sales	6,642	4,690	13,260	9,560
Established Pharmaceutical Products
Revenue
Net sales	1,180	1,013	2,250	2,057
Established Pharmaceutical Products | Int'l
Revenue
Net sales	1,180	1,013	2,250	2,057
Nutritional Products
Revenue
Net sales	2,108	1,883	4,144	3,787
Nutritional Products | U.S.
Revenue
Net sales	873	808	1,709	1,620
Nutritional Products | Int'l
Revenue
Net sales	1,235	1,075	2,435	2,167
Diagnostic Products
Revenue
Net sales	3,247	1,994	7,261	3,820
Diagnostic Products | U.S.
Revenue
Net sales	1,155	857	2,796	1,660
Diagnostic Products | Int'l
Revenue
Net sales	2,092	1,137	4,465	2,160
Medical Devices
Revenue
Net sales	3,666	2,423	6,986	5,360
Medical Devices | U.S.
Revenue
Net sales	1,538	966	2,889	2,199
Medical Devices | Int'l
Revenue
Net sales	2,128	1,457	4,097	3,161
Other
Revenue
Net sales	22	15	38	30
Other | U.S.
Revenue
Net sales	15	7	25	15
Other | Int'l
Revenue
Net sales	7	8	13	15
Key Emerging Markets | Established Pharmaceutical Products
Revenue
Net sales	915	764	1,736	1,577
Key Emerging Markets | Established Pharmaceutical Products | Int'l
Revenue
Net sales	915	764	1,736	1,577
Other | Established Pharmaceutical Products
Revenue
Net sales	265	249	514	480
Other | Established Pharmaceutical Products | Int'l
Revenue
Net sales	265	249	514	480
Pediatric Nutritionals | Nutritional Products
Revenue
Net sales	1,093	1,024	2,159	2,113
Pediatric Nutritionals | Nutritional Products | U.S.
Revenue
Net sales	528	484	1,036	1,002
Pediatric Nutritionals | Nutritional Products | Int'l
Revenue
Net sales	565	540	1,123	1,111
Adult Nutritionals | Nutritional Products
Revenue
Net sales	1,015	859	1,985	1,674
Adult Nutritionals | Nutritional Products | U.S.
Revenue
Net sales	345	324	673	618
Adult Nutritionals | Nutritional Products | Int'l
Revenue
Net sales	670	535	1,312	1,056
Core Laboratory | Diagnostic Products
Revenue
Net sales	1,306	987	2,488	1,976
Core Laboratory | Diagnostic Products | U.S.
Revenue
Net sales	283	289	554	556
Core Laboratory | Diagnostic Products | Int'l
Revenue
Net sales	1,023	698	1,934	1,420
Molecular | Diagnostic Products
Revenue
Net sales	290	359	737	498
Molecular | Diagnostic Products | U.S.
Revenue
Net sales	94	144	269	209
Molecular | Diagnostic Products | Int'l
Revenue
Net sales	196	215	468	289
Point of Care | Diagnostic Products
Revenue
Net sales	137	118	266	256
Point of Care | Diagnostic Products | U.S.
Revenue
Net sales	97	79	189	182
Point of Care | Diagnostic Products | Int'l
Revenue
Net sales	40	39	77	74
Rapid Diagnostics | Diagnostic Products
Revenue
Net sales	1,514	530	3,770	1,090
Rapid Diagnostics | Diagnostic Products | U.S.
Revenue
Net sales	681	345	1,784	713
Rapid Diagnostics | Diagnostic Products | Int'l
Revenue
Net sales	833	185	1,986	377
Rhythm Management | Medical Devices
Revenue
Net sales	567	401	1,086	875
Rhythm Management | Medical Devices | U.S.
Revenue
Net sales	269	185	510	413
Rhythm Management | Medical Devices | Int'l
Revenue
Net sales	298	216	576	462
Electrophysiology | Medical Devices
Revenue
Net sales	487	299	918	687
Electrophysiology | Medical Devices | U.S.
Revenue
Net sales	209	120	388	284
Electrophysiology | Medical Devices | Int'l
Revenue
Net sales	278	179	530	403
Heart Failure | Medical Devices
Revenue
Net sales	227	158	421	361
Heart Failure | Medical Devices | U.S.
Revenue
Net sales	168	115	313	267
Heart Failure | Medical Devices | Int'l
Revenue
Net sales	59	43	108	94
Vascular | Medical Devices
Revenue
Net sales	697	481	1,332	1,106
Vascular | Medical Devices | U.S.
Revenue
Net sales	246	168	465	398
Vascular | Medical Devices | Int'l
Revenue
Net sales	451	313	867	708
Structural Heart | Medical Devices
Revenue
Net sales	422	223	799	541
Structural Heart | Medical Devices | U.S.
Revenue
Net sales	191	91	360	227
Structural Heart | Medical Devices | Int'l
Revenue
Net sales	231	132	439	314
Neuromodulation | Medical Devices
Revenue
Net sales	210	106	394	283
Neuromodulation | Medical Devices | U.S.
Revenue
Net sales	166	85	311	222
Neuromodulation | Medical Devices | Int'l
Revenue
Net sales	44	21	83	61
Diabetes Care | Medical Devices
Revenue
Net sales	1,056	755	2,036	1,507
Diabetes Care | Medical Devices | U.S.
Revenue
Net sales	289	202	542	388
Diabetes Care | Medical Devices | Int'l
Revenue
Net sales	$ 767	$ 553	$ 1,494	$ 1,119

X

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599

+ Details

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_EstablishedPharmaceuticalProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_NutritionalProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_DiagnosticProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_MedicalDevicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_KeyEmergingMarketsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_OtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_PediatricNutritionalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_AdultNutritionalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_CoreLaboratoryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_MolecularMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_PointOfCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_RapidDiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_RhythmManagementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_ElectrophysiologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_HeartFailureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_VascularProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_StructuralHeartMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_NeuromodulationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_DiabetesCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: